ConductScience.org, home

Paper42875487PubMed

Computational design of metalloproteases.

Chen A and 27 others. Nature, 2026.

Cite this record

ConductScience Library. Computational design of metalloproteases. Papers, record 42875487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42875487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computational design of metalloproteases.
Journal
Nature
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-27

Source PubMed

Authors28

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of41332769Computational design of metalloproteases.https://conductscience.org/library/papers/41332769

Source PubMed

Download CSV of comments and corrections

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130545884Evolution of a highly active and enantiospecific metalloenzyme from short peptides.Science2018https://conductscience.org/library/papers/30545884PubMed
241339547Computational design of metallohydrolases.Nature2026https://conductscience.org/library/papers/41339547PubMed
37957888Families of zinc metalloproteases.FEBS Lett1994https://conductscience.org/library/papers/7957888PubMed
411848831Recent Advances in Zinc Enzymology.Chem Rev1996https://conductscience.org/library/papers/11848831PubMed
517318226Matrix metalloproteinases and the regulation of tissue remodelling.Nat Rev Mol Cell Biol2007https://conductscience.org/library/papers/17318226PubMed
618762209The ADAM metalloproteinases.Mol Aspects Med2008https://conductscience.org/library/papers/18762209PubMed
738071234Role of ADAM and ADAMTS proteases in pathological tissue remodeling.Cell Death Discov2023https://conductscience.org/library/papers/38071234PubMed
819461648Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.Hypertens Res2009https://conductscience.org/library/papers/19461648PubMed
923813340Purification and characterization of a new metallo-neutral protease for beer brewing from Bacillus amyloliquefaciens SYB-001.Appl Biochem Biotechnol2013https://conductscience.org/library/papers/23813340PubMed
1021847327Guidelines for the use of botulinum toxin in movement disorders and spasticity.Ann Indian Acad Neurol2011https://conductscience.org/library/papers/21847327PubMed
1112875934Botulinum toxin as a new therapy option for voiding disorders: current state of the art.Eur Urol2003https://conductscience.org/library/papers/12875934PubMed
1231114283Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect.Clin Cosmet Investig Dermatol2019https://conductscience.org/library/papers/31114283PubMed
13258526914-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.Front Immunol2015https://conductscience.org/library/papers/25852691PubMed
1436677656Ultrafast Spectroscopies of Nitrophenols and Nitrophenolates in Solution: From Electronic Dynamics and Vibrational Structures to Photochemical and Environmental Implications.Molecules2023https://conductscience.org/library/papers/36677656PubMed
1537433327De novo design of protein structure and function with RFdiffusion.Nature2023https://conductscience.org/library/papers/37433327PubMed
1639636970Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists.Science2024https://conductscience.org/library/papers/39636970PubMed
1739814879De novo designed proteins neutralize lethal snake venom toxins.Nature2025https://conductscience.org/library/papers/39814879PubMed
1841193805Atomically accurate de novo design of antibodies with RFdiffusion.Nature2026https://conductscience.org/library/papers/41193805PubMed
1925192493Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.J Med Chem2014https://conductscience.org/library/papers/25192493PubMed
2038718835Accurate structure prediction of biomolecular interactions with AlphaFold 3.Nature2024https://conductscience.org/library/papers/38718835PubMed

See all 50 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42875487

GET https://conductscience.org/api/papers/v1/42875487/authors?page=2